In a multi-center cohort of 417 patients with DLB, some authors tested the hypothesis that amyloid-β and tau biomarkers positivity increased with age, was modified by APOE genotype and sex, and that there were synergistic associations with the clinical phenotype [219]. This evidence concerns the gene MAPT and Lewy body dementia.